Childhood- versus Adult-Onset Polyarteritis Nodosa Results from the French Vasculitis Study Group Registry.

Abstract:

OBJECTIVE:To investigate differences between childhood (cPAN)- and adult-onset polyarteritis nodosa (aPAN) patients. METHODS:cPAN patients' clinical findings at onset and outcomes were compared to those of aPAN patients from the French Vasculitis Study Group registry matched for year of enrollment and initial systemic versus cutaneous disease. Their information on medications, disease activity and damage were collected. Kaplan-Meier relapse-free survival curves and the log-rank test were used to analyze cPAN versus aPAN differences for predefined outcomes. RESULTS:Twenty-one children with systemic and 13 with cutaneous PAN were compared with 84 systemic- and 27 cutaneous-matched aPAN patients. Median follow-up exceeded 5 years for both groups. At study entry, mononeuritis multiplex was less frequent in systemic cPAN than systemic aPAN (P = 0.04), and purpura and myalgias were less frequent in cutaneous cPAN than cutaneous aPAN (P < 0.03). During follow-up, systemic cPAN relapsed more often than matched systemic aPAN (P < 0.0001), while relapse rates were similar for cutaneous disease (P > 0.05). Mostly minor relapses, predominantly involving the skin, occurred in all 4 groups. At last visit, damage accrual was comparable for cPAN and aPAN patients, but fewer systemic cPAN patients were treatment-free (15% versus 42%; P = 0.03). Two (6%) cPAN and 8 (7%) aPAN patients died. CONCLUSION:Systemic PAN is equally severe in children and adults and carries a higher risk of relapse. The main cutaneous PAN features seem not to be influenced by age at disease onset.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Iudici M,Quartier P,Pagnoux C,Merlin E,Agard C,Aouba A,Roblot P,Cohen P,Terrier B,Mouthon L,Guillevin L,Puéchal X,French Vasculitis Study Group.

doi

10.1016/j.autrev.2018.08.001

subject

Has Abstract

pub_date

2018-10-01 00:00:00

pages

984-989

issue

10

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(18)30190-3

journal_volume

17

pub_type

杂志文章,评审
  • CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis.

    abstract:BACKGROUND:Myositis is a heterogeneous group of muscular auto-immune diseases with clinical and pathological criteria that allow the classification of patients into different sub-groups. Inclusion body myositis is the most frequent myositis above fifty years of age. Diagnosing inclusion body myositis requires expertise...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2019.02.003

    authors: Dzangué-Tchoupou G,Mariampillai K,Bolko L,Amelin D,Mauhin W,Corneau A,Blanc C,Allenbach Y,Benveniste O

    更新日期:2019-04-01 00:00:00

  • Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM).

    abstract::Type 1 diabetes (T1DM) is an autoimmune disease with aberrant immune responses to specific β-cell autoantigens, resulting in insulin deficiency. Children and adolescents with T1DM may also develop organ-specific multiple autoimmunity in the context of APS (autoimmune polyendocrine syndrome) type 1, 2 or 3. The most fr...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.05.002

    authors: Kakleas K,Soldatou A,Karachaliou F,Karavanaki K

    更新日期:2015-09-01 00:00:00

  • Multiple sclerosis: geoepidemiology, genetics and the environment.

    abstract::Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system characterized by relapses and remissions. The risk of acquiring this complex disease is associated with exposure to environmental factors in genetically susceptible individuals. The epidemiology of MS has been exte...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.010

    authors: Milo R,Kahana E

    更新日期:2010-03-01 00:00:00

  • Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.

    abstract::Intravenous immunoglobulin (IVIg) is used for replacement therapy in immunodeficiency states and for immunomodulation of various autoimmune diseases. Several case reports and series support a beneficial role of IVIg in systemic lupus erythematosus (SLE), both as salvage immunotherapy and in control of disease activity...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.09.002

    authors: Sherer Y,Shoenfeld Y

    更新日期:2006-02-01 00:00:00

  • Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature.

    abstract::Neonatal Lupus Syndrome (NLS) is a distinct clinical entity caused by transplacental passage of maternal anti-SSA/Ro antibodies (Ab). Mothers may have systemic lupus erythematosus, Sjögren syndrome, or other connective tissue disease, or may be completely healthy at the time of giving birth. NLS includes several clini...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.02.010

    authors: Zuppa AA,Riccardi R,Frezza S,Gallini F,Luciano RM,Alighieri G,Romagnoli C,De Carolis S

    更新日期:2017-04-01 00:00:00

  • Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.

    abstract::A few scores predicting the short-term risk of mortality in Systemic sclerosis (SSc) have been reported to date. Our study aimed to create a predictive 15-year all-cause mortality score at the time of the diagnosis of SSc. The study was based on the Spanish Scleroderma Registry (RESCLE). The cohort was split up in der...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102507

    authors: Rubio-Rivas M,Corbella X,Guillén-Del-Castillo A,Tolosa Vilella C,Colunga Argüelles D,Argibay A,Vargas Hitos JA,Todolí Parra JA,González-Echávarri C,Ortego-Centeno N,Trapiella Martínez L,Rodríguez Carballeira M,Marín Ballvé A,Pl

    更新日期:2020-05-01 00:00:00

  • Regulation of neurovascular coupling in autoimmunity to water and ion channels.

    abstract::Much progress has been made in understanding autoimmune channelopathies, but the underlying pathogenic mechanisms are not always clear due to broad expression of some channel proteins. Recent studies show that autoimmune conditions that interfere with neurovascular coupling in the central nervous system (CNS) can lead...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.11.010

    authors: Jukkola P,Gu C

    更新日期:2015-03-01 00:00:00

  • Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity.

    abstract::Since many years immunologists have being tried to answer the tantalizing enigma of immunological tolerance. Complex mechanisms in both thymus (central tolerance) and peripheral lymphoid organs (peripheral tolerance) underly lymphocyte tolerance and its maintenance. The genesis of autoimmunity involves environmental a...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.08.019

    authors: Fierabracci A

    更新日期:2011-01-01 00:00:00

  • Autoimmune and proinflammatory activity of oxidized immunoglobulins.

    abstract:AIMS:Oxidation reactions can modify protein activity or specificity. Recently, a novel redox-reactive family of autoantibodies was described, which indicated involvement of altered antibodies (beside altered antigens) into autoimmune reactions. The aim of our study was to determine the binding capacity alterations of e...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2008.04.005

    authors: Omersel J,Jurgec I,Cucnik S,Kveder T,Rozman B,Sodin-Semrl S,Bozic B

    更新日期:2008-07-01 00:00:00

  • "How I treat" autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis.

    abstract::This Special Issue of Autoimmunity Reviews constitutes summaries of presentations at the 20th International Meeting on Immunopathology and Orphan Diseases, held in Torino, Italy, 25-28th January 2017. As such, these presentations represent the state of the art on the pathophysiology of autoimmune diseases as well as t...

    journal_title:Autoimmunity reviews

    pub_type: 社论

    doi:10.1016/j.autrev.2017.07.015

    authors: Roccatello D

    更新日期:2017-10-01 00:00:00

  • Adrenal insufficiency in systematic lupus erythematosus (SLE) and antiphospholipid syndrome (APS): A systematic review.

    abstract:BACKGROUND:Adrenal insufficiency (AI) is associated with high morbidity and mortality. The aim of this systematic review was to enhance diagnostic approaches and summarize therapeutic strategies in the management of AI in patients with systematic lupus erythematosus (SLE) or antiphospholipid syndrome (APS). METHODS:A ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2018.06.014

    authors: Lee KH,Lee H,Lee CH,Kim JY,Kim JM,Kim SS,Jeong S,Hwang IS,Kim N,Kim NE,Shin S,Shin D,Song JS,Shin DH,Kim JD,Kim J,Lee YS,Kang H,Kim DH,Moon SH,Rho WS,Lee JY,Kronbichler A,Shin JI

    更新日期:2019-01-01 00:00:00

  • Follicular helper T cells poise immune responses to the development of autoimmune pathology.

    abstract::Follicular helper T cells (T(FH)) have been implicated as a lineage that provides sufficient help to B cells in order to become professional antibody producers. This T helper subset is characterized by a distinctive cell-surface phenotype (CD4(+)CD57(+)CXCR5(+)) and cytokine profile (IL-21, IL-6, and IL-27) as well as...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.11.007

    authors: Gómez-Martín D,Díaz-Zamudio M,Romo-Tena J,Ibarra-Sánchez MJ,Alcocer-Varela J

    更新日期:2011-04-01 00:00:00

  • Benefits and burden of the maternally-mediated immunological imprinting.

    abstract::The ontogenetic development of both the immune and the nervous system entirely depend on external environmental signals that induce a lifelong learning process. The resulting collective immunological knowledge about the external world is transmitted in an epi-genetic fashion to the offspring, but only from the materna...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.12.005

    authors: Lemke H,Tanasa RI,Trad A,Lange H

    更新日期:2009-03-01 00:00:00

  • Cortactin autoantibodies in myasthenia gravis.

    abstract::Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness, fatigability, and autoantibodies against protein antigens of the muscle endplate. Antibodies against acetylcholine receptor (AChR), and less frequently against muscle-Specific Kinase (MuSK) or lipoprotein related protein 4 (LRP4) occur i...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2014.08.039

    authors: Gallardo E,Martínez-Hernández E,Titulaer MJ,Huijbers MG,Martínez MA,Ramos A,Querol L,Díaz-Manera J,Rojas-García R,Hayworth CR,Verschuuren JJ,Balice-Gordon R,Dalmau J,Illa I

    更新日期:2014-10-01 00:00:00

  • Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases.

    abstract::Intravenous immunoglobulin (IVIG) is efficient in various immune mediated conditions. Various cardiovascular diseases are mediated by inflammatory processes and autoimmune mechanisms. Therefore, it seems conceivable to employ IVIG as an immunomodulating therapy in such indications. In this paper we review the possible...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.04.001

    authors: Nussinovitch U,Shoenfeld Y

    更新日期:2008-06-01 00:00:00

  • The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity.

    abstract::IgG4-related disease is a distinct clinical entity, whose characteristic features are the following; Serum IgG4 is prominently elevated, IgG4-positive plasma cells infiltrate in involved tissues, various mass-forming lesions with fibrosis develop in a timely and spatial manner and the response to corticosteroids is pr...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.05.003

    authors: Takahashi H,Yamamoto M,Suzuki C,Naishiro Y,Shinomura Y,Imai K

    更新日期:2010-07-01 00:00:00

  • Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity.

    abstract::Systemic lupus erythematosus (SLE) is a chronic immune-mediated inflammatory multisystem disease. The onset of viral and bacterial infections may favor the exacerbation of the disease, amplify autoimmune processes and contribute to mortality and morbidity. The prevention of influenza and Streptococcus pneumoniae infec...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.07.007

    authors: Murdaca G,Orsi A,Spanò F,Puppo F,Durando P,Icardi G,Ansaldi F

    更新日期:2014-02-01 00:00:00

  • B cells and HCV: an infection model of autoimmunity.

    abstract::In addition to cause acute and chronic liver disease, hepatitis C virus (HCV) infection is frequently associated to autoimmune disorders, such as mixed cryoglobulinemia, primary glomerulonephritis, monoclonal gammopathy of undetermined significance and post-transplant proliferative disorders. Progression to malignant ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.03.008

    authors: Sansonno L,Tucci FA,Sansonno S,Lauletta G,Troiani L,Sansonno D

    更新日期:2009-12-01 00:00:00

  • Biosimilars from a practicing rheumatologist perspective: An overview.

    abstract::The earliest experimental trials of monoclonal antibodies took place in the early 1980s using murine monoclonal antibodies directed at human lymphoma and leukemia cell antigens. Since those early trials, therapeutic advances have produced monoclonal antibodies and fusion proteins that are now used in multiple disease ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.07.001

    authors: Schimizzi GF

    更新日期:2016-09-01 00:00:00

  • The future landscape of biosimilars in rheumatology: Where we are where we are going.

    abstract:INTRODUCTION:The upcoming of biosimilars in rheumatic diseases have generated considerable interest throughout the past five years among pharmaceutical industries and regulatory agencies, their development is associated with considerable variation and heterogeneity on the variable requirements for license and marketing...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.09.005

    authors: Scheinberg M,Azevedo V

    更新日期:2019-02-01 00:00:00

  • Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4.

    abstract::Myasthenia gravis is caused by antibodies to the acetylcholine receptor, muscle-specific kinase, low-density lipoprotein receptor-related protein 4, or possibly yet unidentified antibodies. The mechanisms by which these antibodies interfere with the function of postsynaptic proteins include complement activation, anti...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.03.001

    authors: Verschuuren JJ,Huijbers MG,Plomp JJ,Niks EH,Molenaar PC,Martinez-Martinez P,Gomez AM,De Baets MH,Losen M

    更新日期:2013-07-01 00:00:00

  • Pulmonary manifestations in antiphospholipid syndrome.

    abstract::Pulmonary manifestations in antiphospholipid syndrome (APS) are relatively rare compared to other clinical signs of this disease. However, pulmonary microthrombosis is among the most frequent arterial complications of APS. Timely diagnosis of pulmonary manifestations is required due both to their severity and to the h...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.02.002

    authors: Stojanovich L

    更新日期:2006-05-01 00:00:00

  • Vitamin D and systemic lupus erythematosus - The hype and the hope.

    abstract::Over the past 20years, much has been written about the potential role of vitamin D in on adverse health outcomes. In recent years, evidence has accumulated regarding the effect of vitamin D on the immune system, and its different cells. Some studies have noted lower vitamin D concentrations in patients with SLE. These...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.11.004

    authors: Shoenfeld Y,Giacomelli R,Azrielant S,Berardicurti O,Reynolds JA,Bruce IN

    更新日期:2018-01-01 00:00:00

  • Integrins: a flexible platform for endothelial vascular tyrosine kinase receptors.

    abstract::Compared to lower metazoans, vertebrates built up an exclusively new set of adhesion-related genes involved in the tissue development and in their functions. They include a large variety of extracellular matrix proteins and their heterodimeric integrin adhesive receptors. Integrins control the adhesive state of the ce...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.03.007

    authors: Napione L,Cascone I,Mitola S,Serini G,Bussolino F

    更新日期:2007-11-01 00:00:00

  • Modulation of autoimmunity with artificial peptides.

    abstract::The loss of immune tolerance to self antigens leads to the development of autoimmune responses. Since self antigens are often multiple and/or their sequences may be known, one approach to restore immune tolerance uses synthetic artificial peptides that interfere or compete with self peptides in the networks of cellula...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.08.017

    authors: La Cava A

    更新日期:2010-11-01 00:00:00

  • Autoimmune blistering diseases of the skin.

    abstract::Autoimmune skin diseases represent a heterogeneous group of disorders with grossly diverging clinical manifestations but partly shared underlying immunological mechanisms. They may affect the skin as an isolated organ or among systemic diseases. In addition unspecific cutaneous symptoms or drug-induced unwanted effect...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.05.017

    authors: Sticherling M,Erfurt-Berge C

    更新日期:2012-01-01 00:00:00

  • Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis.

    abstract::Antineutrophil cytoplasmic antibodies (ANCA) are the serological hallmark of some idiopathic systemic vasculitides, such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and, to a lesser extent, Churg-Strauss syndrome (CCS), the so-called ANCA-associated vasculitides (AAV). ANCA were first det...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.08.008

    authors: Radice A,Bianchi L,Sinico RA

    更新日期:2013-02-01 00:00:00

  • Common variable immunodeficiency and autoimmunity--an inconvenient truth.

    abstract::Coexisting morbidities in CVID include bronchiectasis, autoimmunity and malignancies. The incidence of autoimmune disease in CVID patients may approach 20% of cases. The most common autoimmune disease found in CVID patients is autoimmune cytopenia, but rheumatoid arthritis, lupus, and now primary biliary cirrhosis hav...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.04.006

    authors: Xiao X,Miao Q,Chang C,Gershwin ME,Ma X

    更新日期:2014-08-01 00:00:00

  • Rho GTPase-mediated pathways in mature CD4+ T cells.

    abstract::Effective immune responses require the appropriate activation and differentiation of peripheral CD4(+) T cells. These processes need to be followed by the timely elimination of the responding T cells in order to restore T cell homeostasis. Defects in the appropriate regulation of T cell activation, expansion, and surv...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.07.044

    authors: Pernis AB

    更新日期:2009-01-01 00:00:00

  • Human FoxP3+ regulatory T cells in systemic autoimmune diseases.

    abstract::Since the characterization of CD4(+)CD25(+) regulatory T (Treg) cells in mice, significant progress has been made in the definitions of the phenotype and the function of human Treg cells in health and in pathological conditions. Recent advances in the field leading to a better molecular definition of Treg subsets in h...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.05.004

    authors: Miyara M,Gorochov G,Ehrenstein M,Musset L,Sakaguchi S,Amoura Z

    更新日期:2011-10-01 00:00:00